Arvee Laboratories (India) growth over the years

·UnclassifiedChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr3 yr
Revenue−18.1%−20.4%
EBITDA−11.5%−27.6%
Net Income+17.7%−15.0%
EPS (adj.)+17.7%−15.0%
Total Assets+13.4%+3.8%
Total Equity+8.1%+6.4%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

ARVEE₹182.00

Arvee Laboratories (India) Limited

· Unclassified
₹ CrorePeersSPCENETGVPTECHMCLNITIRAJASPINWALLJMASINTERCOMMcap ₹201 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue-18.1-20.4
EBITDA-11.5-27.6
Net Income+17.7-15.0
EPS (adj.)+17.7-15.0
Total Assets+13.4+3.8
Total Equity+8.1+6.4
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.